Lupus alpha Micro Champions CAV


ISIN: LU0218245263

Lupus alpha Micro Champions invests predominantly in European micro caps, utilizing a focused bottom-up strategy. This segment is mostly comprised of niche players with above-average return potential. The strategy uses quantitative fundamental analysis and qualitative methods to identify these stocks for investors.


Fund data

Current fund data as of 10/29/2020

Currency EUR
Issue price 166.13
Redemption price 158.22
Fund volume 72,95 Mio.
Launch date 16 June 2005
Minimum investment amount 500.000
Distribution frequency 6distribution
Portfolio managers Jonas Liegl
Administration fee 52 %
Subscription fee 4up to 5 %
Morningstar Rating ★★★★★
Fund price publication
  • Source: Lupus alpha; gross performance (BVI method): The gross performance considers all costs incurred at Fund level (e. g. management fee) and assumes reinvestment of any distributions. Costs incurred at customer level such as sales charge and securities account costs are not included. Unless otherwise specified, all indicated performance data show the gross performance. Please note: Past performance is not a reliable indicator for future performance.
  • The sales charge is the difference between the sales price and the unit value. The sales charge varies depending on the type of the Fund and the distribution channel and usually covers the advisory and distribution costs. The Distributor will demand the sales charge at its own discretion.
  • Volatility is the range of variation of a security price or index around its mean value over a fixed period of time. A security is regarded as volatile if its price fluctuates heavily. The tracking error describes the standard deviation (volatility) between the Fund's performance and the performance of the benchmark index. The higher the tracking error, the more the performance of the Fund deviates from the performance of the benchmark index. The investment ratio means the part of the Fund that is not invested in cash.
  • The management fee is the fee for managing the Fund and taken from the Fund's assets; it is paid to Lupus alpha for the management and administration of the Fund.
  • Distributing Funds do not reinvest the generated income, they pay out the income to the investor.
  • Morningstar Rating™ Total: © (2019) Morningstar Inc. All Rights Reserved. The information contained herein: 1. is intended for Morningstar and/or its content providers. 2. may not be reproduced or distributed; and 3. their accuracy, completeness or timeliness is not guaranteed. Neither Morningstar nor their content providers are responsible for any damages or losses arising from the use of this information. Ratings related to the previous month.

Performance chart

Performance since 01.07.2014: +1.75 %
As of: 31.07.2014

Performance (gross in EUR):¹

fromtoLupus alpha Micro Champions CAVEuro Stoxx® Small Return Index
1 month 31.08.202030.09.20203.02 %-1.47 %
90 days 02.07.202030.09.202014.79 %1.54 %
1 year 30.09.201930.09.202017.84 %0.91 %
3 years 29.09.201730.09.202029.21 %4.02 %
5 years 30.09.201530.09.202099.80 %36.63 %
this year 31.12.201930.09.20209.82 %-5.92 %
since inception 16.06.200530.09.2020232.11 %127.14 %
since inception p.a. 16.06.200530.09.20208.16 %5.51 %

12-month-timeframe (gross)Lupus alpha Micro Champions CAVEuro Stoxx® Small Return Index
30.09.2019 - 30.09.202017.84 %0.91 %
30.09.2018 - 30.09.20190.87 %3.88 %
30.09.2017 - 30.09.20189.38 %-0.26 %
30.09.2016 - 30.09.201745.07 %28.68 %
30.09.2015 - 30.09.20166.18 %2.57 %
30.09.2014 - 30.09.201523.84 %7.33 %
30.09.2013 - 30.09.201410.45 %7.63 %
30.09.2012 - 30.09.201324.30 %23.57 %
30.09.2011 - 30.09.201211.24 %8.64 %
30.09.2010 - 30.09.2011-4.25 %-13.16 %

Key Risk ratios (gross):³

as ofLupus alpha Micro Champions CAVEuro Stoxx® Small Return Index
Volatility p.a. 30.09.202013.61 %20.02 %
Tracking Error 30.09.202011.34 %n.a.
Investment rate 30.09.202095.73 %n.a.
Fund structure

Top ten holdings as of 30/09/2020

Crayon Group Holding AS
Frauenthal Holding AG
Init Innovation In Traffic Systems
Marinomet Biotech AG
Noratis AG
Sword Group
Uniphar PLC
Vivoryon Therapeutics AG
Wallstreet:Online AG
Total stocks: 73
Total weight of top ten: 25.76 %

Sector allocation as of 30/09/2020

Country allocation as of 30/09/2020

  • Return potential of attractive micro caps as promising investments
  • Largely undiscovered equity segment with a high degree of inefficiency
  • Clearly focused on European micro caps with a market capitalisation of €50 to €750 million
  • Uncompromising bottom-up strategy: face-to-face meetings with management a clear priority
  • Broad diversification across sectors and countries helps to reduces potentially higher volatility
Team expertise

The portfolio management team draws upon all of Lupus alpha’s specialist expertise in the small- and mid-cap segment:

  • Large European small- and mid-cap team with nine specialists
  • Many years of experience and an exceptional track record
  • Wide range of monitored stocks/companies
  • Detailed knowledge gained from approximately 1,000 points of contact with companies each year

€uro Fund Award 2020:

2nd place in the category "Aktienfonds Europa Nebenwerte" five-year performance   

2nd place in the category "Aktienfonds Europa Nebenwerte" three-year performance


Lipper Fund Award 2019


Investment concept

Bottom-up strategy for European micro caps


Lupus alpha Micro Champions invests predominantly in European micro caps utilizing a focused bottom-up strategy. They rarely appear on most asset managers' radar screens due to their small size. The resulting market inefficiencies are essential for above-average yields. Our fund managers can use fundamental equity research to gain significant information advantages and exploit attractive return opportunities. The combination of meticulous stock selection and broad diversification across sectors and countries reduces the high volatilities at portfolio level compared to large-cap stocks.


European micro caps are often niche players with a focused business model, above-average return potential and high growth potential. You can now make the most of their advantages, as these niche segments are often too 'narrow' for most major corporations and thus less interesting to them. Micro caps' high degree of specialisation also acts as a high barrier to entry for potential competitors. Nevertheless, attractive micro caps cannot be unearthed while sitting behind a desk: when selecting stocks, the most crucial element for Lupus alpha, apart from quantitative fundamental, analysis is to qualitatively assess the management. As part of this concept our team of specialists hold intensive meetings with management to build a picture of a company's unique features and potential in person. Only a focused bottom-up strategy like this enables us to open up the unique return potential of European micro caps to investors over the long term.


Investment objective

The objective of Lupus alpha Micro Champions is to outperform the benchmark index (DJ EURO STOXX® Small Return) over the long term.

Chances and Risks

The value of investments and the income from them can go down as well as up and you may get back less than the amount invested.

A full list of risks applicable to this fund can be found in the Prospectus.


This fund information is provided for general information purposes. This information is not designed to replace the investor's own market research nor any other legal, tax or financial information or advice. The information presented does not constitute an invitation to buy or sell or investment advice. It does not contain all key information required to make important economic decisions and may differ from information and estimates provided by other sources or market participants. We accept no liability for the accuracy, completeness or topicality of this information. All statements are based on our assessment of the present legal and tax situation. All opinions reflect the current views of the portfolio manager and can be changed without prior notice. 

Full details of our funds and their licenses of distribution can be found in the relevant current sales prospectus and, where appropriate, Key Investor Information Document , supplemented by the latest audited annual report and/or half-year report. 

The relevant sales prospectus and Key Investor Information Documents prepared in German are the sole legally-binding basis for the purchase of funds managed by Lupus alpha Investment GmbH. You can obtain these documents free of charge from Lupus alpha Investment GmbH, P.O. Box 11 12 62, 60047 Frankfurt am Main, upon request by calling +49 69 365058-7000, by emailing or via our website: If funds are licensed for distribution in  Austria the respective sales prospectus, Key Investor Information Document and the latest audited annual report or half-year report are available from the Austrian paying and information agent UniCredit Bank Austria AG based in A-1020 Vienna, Rothschildplatz 1. Fund units can be obtained from banks, savings banks and independent financial advisors.


Neither this fund information, nor its contents, nor any copy thereof may be sent to third parties, changed in any way or copied without the prior written consent of Lupus alpha Investment GmbH. By accepting this document you agree to comply with the provisions above. Subject to change without notice.




Lipper Fund Awards from Refinitiv 2019€uro Fund Award 2020

Portfolio Manager

Experienced fund manager


Jonas Liegl, the experienced small- and mid-cap fund manager, has more than 10 years of experience in the analysis and portfolio management of European micro-, small- and mid-caps for large institutional mandates.


Jonas Liegl
CFA, Portfolio Management Small & Mid Caps Europa